naltrexone has been researched along with Binge-Eating Disorder in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (58.33) | 24.3611 |
| 2020's | 5 (41.67) | 2.80 |
| Authors | Studies |
|---|---|
| Billman, M; Essayli, J; Lane-Loney, S; Mahr, F; Roden, RC; Ryan, S; Vrana, K | 1 |
| Fineberg, SK; Grilo, CM; Gueorguieva, R; Ivezaj, V; Lydecker, JA; Moreno, JO | 1 |
| Font, L; Morales, I; Pastor, R; Rodríguez-Borillo, O | 1 |
| Aloi, M; Arturi, F; Calabrò, G; Carbone, EA; Caroleo, M; Condoleo, F; de Filippis, R; Rania, M; Segura-Garcia, C; Staltari, FA | 1 |
| Grilo, CM; Gueorguieva, R; Lydecker, JA; Morgan, PT | 1 |
| Dunayevich, E; Guerdjikova, AI; Halseth, AE; McElroy, SL; Shan, K; Walsh, B | 1 |
| Abdel-Rahman, S; Adelman, W; Dietz, A; Stancil, SL | 1 |
| Acree, M; Adler, N; Bacchetti, P; Brown, RR; Dallman, M; Daubenmier, J; Epel, ES; Hecht, FM; Laraia, B; Lustig, RH; Mason, AE; Moran, PJ | 1 |
| Baroni, S; DellʼOsso, L; Marazziti, D; Piccinni, A | 1 |
| Bordet, R; Carton, L; Cottencin, O; Gomajee, H; Leroy, A | 1 |
| Bullmore, ET; Everitt, BJ; Giuliano, C; Nathan, PJ; Robbins, TW | 1 |
| Blasio, A; Cottone, P; Sabino, V; Steardo, L | 1 |
5 trial(s) available for naltrexone and Binge-Eating Disorder
| Article | Year |
|---|---|
An experimental protocol for a double-blind placebo-controlled evaluation of the effectiveness of oral naltrexone in management of adolescent eating disorders.
Topics: Adolescent; Anorexia Nervosa; Binge-Eating Disorder; Bulimia; Bulimia Nervosa; Feeding and Eating Disorders; Humans; Naltrexone; Randomized Controlled Trials as Topic; Young Adult | 2022 |
Naltrexone-Bupropion and Behavior Therapy, Alone and Combined, for Binge-Eating Disorder: Randomized Double-Blind Placebo-Controlled Trial.
Topics: Behavior Therapy; Binge-Eating Disorder; Bupropion; Double-Blind Method; Female; Humans; Male; Middle Aged; Naltrexone; Obesity; Treatment Outcome; Weight Loss | 2022 |
An open-label trial on the efficacy and tolerability of naltrexone/bupropion SR for treating altered eating behaviours and weight loss in binge eating disorder.
Topics: Binge-Eating Disorder; Bupropion; Case-Control Studies; Feeding Behavior; Humans; Naltrexone; Weight Loss | 2021 |
Naltrexone + Bupropion Combination for the Treatment of Binge-eating Disorder with Obesity: A Randomized, Controlled Pilot Study.
Topics: Adult; Anti-Obesity Agents; Binge-Eating Disorder; Body Weight; Bupropion; Double-Blind Method; Drug Combinations; Female; Humans; Male; Middle Aged; Naltrexone; Obesity; Pilot Projects; Treatment Outcome | 2021 |
Acute responses to opioidergic blockade as a biomarker of hedonic eating among obese women enrolled in a mindfulness-based weight loss intervention trial.
Topics: Adult; Behavior, Addictive; Binge-Eating Disorder; Body Mass Index; Body Weight; Bulimia; Eating; Emotions; Female; Humans; Hydrocortisone; Middle Aged; Mindfulness; Motivation; Naltrexone; Narcotic Antagonists; Nausea; Obesity; Opioid Peptides; Receptors, Opioid; Reward; Stress, Psychological; Weight Reduction Programs | 2015 |
7 other study(ies) available for naltrexone and Binge-Eating Disorder
| Article | Year |
|---|---|
Effects of naltrexone on alcohol, sucrose, and saccharin binge-like drinking in C57BL/6J mice: a study with a multiple bottle choice procedure.
Topics: Animals; Behavior, Addictive; Binge Drinking; Binge-Eating Disorder; Ethanol; Male; Mice; Mice, Inbred C57BL; Models, Animal; Naltrexone; Narcotic Antagonists; Saccharin; Self Administration; Sucrose | 2020 |
Concurrent Improvement in Both Binge Eating and Depressive Symptoms with Naltrexone/Bupropion Therapy in Overweight or Obese Subjects with Major Depressive Disorder in an Open-Label, Uncontrolled Study.
Topics: Adult; Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Binge-Eating Disorder; Bupropion; Comorbidity; Depressive Disorder, Major; Female; Humans; Middle Aged; Naltrexone; Narcotic Antagonists; Obesity; Overweight | 2017 |
Naltrexone Reduces Binge Eating and Purging in Adolescents in an Eating Disorder Program.
Topics: Adolescent; Binge-Eating Disorder; Bulimia Nervosa; Female; Humans; Male; Naltrexone; Narcotic Antagonists; Off-Label Use; Retrospective Studies; Vomiting | 2019 |
Effectiveness of Nalmefene in Binge Eating Disorder: A Case Report.
Topics: Adult; Appetite Depressants; Binge-Eating Disorder; Female; Humans; Naltrexone; Treatment Outcome | 2016 |
Naltrexone in the treatment of binge eating disorder in a patient with severe alcohol use disorder: a case report.
Topics: Alcohol-Related Disorders; Binge-Eating Disorder; Humans; Male; Middle Aged; Naltrexone; Narcotic Antagonists | 2017 |
Inhibition of opioid transmission at the μ-opioid receptor prevents both food seeking and binge-like eating.
Topics: Animals; Avoidance Learning; Binge-Eating Disorder; Conditioning, Operant; Feeding Behavior; Female; Food Preferences; Indans; Male; Naltrexone; Narcotic Antagonists; Rats; Receptors, Opioid, mu; Reinforcement Schedule; Synaptic Transmission; Triazoles | 2012 |
Opioid system in the medial prefrontal cortex mediates binge-like eating.
Topics: Analysis of Variance; Animals; Binge-Eating Disorder; Conditioning, Operant; Disease Models, Animal; Feeding Behavior; Male; Motivation; Naltrexone; Narcotic Antagonists; Opioid Peptides; Prefrontal Cortex; Rats; Rats, Wistar; Reinforcement, Psychology | 2014 |